Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study. [PDF]
Mateoc T +8 more
europepmc +1 more source
Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists. [PDF]
Cosentino N +6 more
europepmc +1 more source
Using the Power Wheel as a transformative tool to promote equity through spaces and places of patient engagement. [PDF]
Sayani A +21 more
europepmc +1 more source
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort. [PDF]
Giesen A +21 more
europepmc +1 more source
Reply: Balancing Promise and Evidence: Critical Perspectives on SGLT2 Inhibitors for Cardiotoxicity Prevention. [PDF]
Bhatti AW +4 more
europepmc +1 more source
Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations. [PDF]
Wang Z, Wang Y, Shangguan W, Li T.
europepmc +1 more source
Emerging data on SGLT2 benefits in acute coronary syndromes. [PDF]
Rawshani A.
europepmc +1 more source
Association of sodium-glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis. [PDF]
Maremmani M +7 more
europepmc +1 more source

